Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

A combinatorial mechanism for determining the specificity of E2F activation and repression.

Freedman JA, Chang JT, Jakoi L, Nevins JR.

Oncogene. 2009 Aug 13;28(32):2873-81. doi: 10.1038/onc.2009.153. Epub 2009 Jun 22.

2.

Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation.

de Bruin A, Maiti B, Jakoi L, Timmers C, Buerki R, Leone G.

J Biol Chem. 2003 Oct 24;278(43):42041-9. Epub 2003 Jul 31.

3.

E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control.

Gaubatz S, Lindeman GJ, Ishida S, Jakoi L, Nevins JR, Livingston DM, Rempel RE.

Mol Cell. 2000 Sep;6(3):729-35.

4.

Loss of E2F4 activity leads to abnormal development of multiple cellular lineages.

Rempel RE, Saenz-Robles MT, Storms R, Morham S, Ishida S, Engel A, Jakoi L, Melhem MF, Pipas JM, Smith C, Nevins JR.

Mol Cell. 2000 Aug;6(2):293-306.

5.

Identification of a novel E2F3 product suggests a mechanism for determining specificity of repression by Rb proteins.

Leone G, Nuckolls F, Ishida S, Adams M, Sears R, Jakoi L, Miron A, Nevins JR.

Mol Cell Biol. 2000 May;20(10):3626-32.

6.

Collaborative role of E2F transcriptional activity and G1 cyclindependent kinase activity in the induction of S phase.

Leone G, DeGregori J, Jakoi L, Cook JG, Nevins JR.

Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6626-31.

7.

E2F3 activity is regulated during the cell cycle and is required for the induction of S phase.

Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS, Nevins JR.

Genes Dev. 1998 Jul 15;12(14):2120-30.

8.

E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2.

Kowalik TF, DeGregori J, Leone G, Jakoi L, Nevins JR.

Cell Growth Differ. 1998 Feb;9(2):113-8.

9.

Role of the Rb/E2F pathway in cell growth control.

Nevins JR, Leone G, DeGregori J, Jakoi L.

J Cell Physiol. 1997 Nov;173(2):233-6. Review. No abstract available.

PMID:
9365528
10.

Distinct roles for E2F proteins in cell growth control and apoptosis.

DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR.

Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7245-50.

11.

Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F.

Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR.

Nature. 1997 May 22;387(6631):422-6. Erratum in: Nature 1997 Jun 26;387(6636):932.

PMID:
9163430
12.

Functional analysis of E2F transcription factor.

Nevins JR, DeGregori J, Jakoi L, Leone G.

Methods Enzymol. 1997;283:205-19. No abstract available.

PMID:
9251021
13.

The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state.

Smith EJ, Leone G, DeGregori J, Jakoi L, Nevins JR.

Mol Cell Biol. 1996 Dec;16(12):6965-76.

14.

A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation.

Ikeda MA, Jakoi L, Nevins JR.

Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3215-20.

15.

Oncogenic capacity of the E2F1 gene.

Johnson DG, Cress WD, Jakoi L, Nevins JR.

Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12823-7.

16.

Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.

Schwarz JK, Devoto SH, Smith EJ, Chellappan SP, Jakoi L, Nevins JR.

EMBO J. 1993 Mar;12(3):1013-20.

17.

The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding.

Yee AS, Raychaudhuri P, Jakoi L, Nevins JR.

Mol Cell Biol. 1989 Feb;9(2):578-85.

18.

Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages.

Prpic V, Uhing RJ, Weiel JE, Jakoi L, Gawdi G, Herman B, Adams DO.

J Cell Biol. 1988 Jul;107(1):363-72. Erratum in: J Cell Biol 1988 Sep;107(3):following 1260.

19.

Binding of alpha 2-macroglobulin-thrombin complexes and methylamine-treated alpha 2-macroglobulin to human blood monocytes.

Straight DL, Jakoi L, McKee PA, Snyderman R.

Biochemistry. 1988 Apr 19;27(8):2885-90.

PMID:
2456779
20.

Leukocyte chemoattraction by 1,2-diacylglycerol.

Wright TM, Hoffman RD, Nishijima J, Jakoi L, Snyderman R, Shin HS.

Proc Natl Acad Sci U S A. 1988 Mar;85(6):1869-73.

21.

Role of a guanine nucleotide regulatory protein in the activation of phospholipase C by different chemoattractants.

Verghese MW, Charles L, Jakoi L, Dillon SB, Snyderman R.

J Immunol. 1987 Jun 15;138(12):4374-80.

PMID:
3108387
22.
25.

Effect of apolipoproteins on the induction of hepatic steatosis in rats.

Quarfordt SH, Shelburne FA, Meyers W, Jakoi L, Hanks J.

Gastroenterology. 1981 Jan;80(1):149-53.

PMID:
7450399
26.

Selective biliary secretion of basal and glucagon-inhibited neutral sterol after triparanol administration.

Meyers WC, Hanks JB, Jakoi L, Quarfordt S, Jones RS.

Surgery. 1980 Jul;88(1):156-61.

PMID:
7385018
27.

The sources of rat biliary cholesterol and bile acid.

Long TT 3rd, Jakoi L, Stevens R, Quarfordt S.

J Lipid Res. 1978 Sep;19(7):872-8.

28.

The heterogeneity of rat high density lipoproteins.

Quarfordt SH, Jain RS, Jakoi L, Robinson S, Shelburne F.

Biochem Biophys Res Commun. 1978 Aug 14;83(3):786-93. No abstract available.

PMID:
213069
29.

Alterations of rat hepatic cholesterogenesis by heterologous lipoproteins.

Jakoi L, Quarfordt SH.

J Biol Chem. 1977 Oct 10;252(19):6856-60.

30.

The induction of hepatic cholesterol synthesis in the rat by lecithin mesophase infusions.

Jakoi L, Quarfordt SH.

J Biol Chem. 1974 Sep 25;249(18):5840-4. No abstract available.

31.

Effect of biliary obstruction on canine plasma and biliary lipids.

Quarfordt SH, Oelschlaeger H, Krigbaum WR, Jakoi L, Davis R.

Lipids. 1973 Sep;8(9):522-30. No abstract available.

PMID:
4355151
32.

A method for semiautomatic differential analysis of urinary catecholamines.

Hathaway PW, Jakoi L, Troyer WG Jr, Bogdonoff MD.

Anal Biochem. 1967 Sep;20(3):466-76. No abstract available.

PMID:
6048185

Supplemental Content

Support Center